<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778384</url>
  </required_header>
  <id_info>
    <org_study_id>Intervention_Pain_Therapy</org_study_id>
    <nct_id>NCT04778384</nct_id>
  </id_info>
  <brief_title>Patient Education to Promote Self-management in Pain Therapy</brief_title>
  <official_title>Evaluation of the Effectiveness of a Patient Education for Oncological Patients to Promote Self-management in Pain Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monocentric, uncontrolled before / after study to evaluate the effectiveness of a patient&#xD;
      education for oncological patients by nursing staff to promote self-management in pain&#xD;
      therapy.&#xD;
&#xD;
      The structured patient education (in the form of a micro-training) is intended to&#xD;
      specifically promote pain self-management in oncological patients. In contrast to&#xD;
      conventional training courses, this requires the patient to be actively involved in the&#xD;
      process so that the skills learned can be used to optimally adapt the therapy on an&#xD;
      individual level. Through the intervention, we postulate the advantage that the increased&#xD;
      self-management of pain therapy improves the everyday functions of the patient, and by&#xD;
      breaking down patient-related barriers and checking the accessibility of pain medication, the&#xD;
      safety in dealing with pain therapy and thus patient satisfaction increases.&#xD;
&#xD;
      Data is collected in two time series. First, data of patients with sham intervention (control&#xD;
      intervention) is collected, then data is collected from patients with a structured&#xD;
      micro-training (study intervention). Patients do not know which training series they belong&#xD;
      to.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nursing staff is trained to conduct the micro-training. The sham intervention is unstructured&#xD;
      at the discretion of the respective nurse. They are only informed about the purpose of the&#xD;
      sham intervention, the expected time frame and the course of a sample sham intervention.&#xD;
&#xD;
      First, the data collection of the group with control intervention is started until the&#xD;
      required number of patients is recorded. As soon as these data are complete, the group with&#xD;
      study intervention is recorded.&#xD;
&#xD;
      The patients are recruited from the oncological outpatient clinics. After the outpatient&#xD;
      clinics before a parenteral therapy, they have a waiting period, during which the patient's&#xD;
      consent is obtained. The patients are then taken to the intervention room for parenteral&#xD;
      therapy. Here, the questionnaire is filled out before, during or after the therapy, and then&#xD;
      the intervention with the nurse takes place. This process with a short reflection period must&#xD;
      be designed in such a way because the indication for escalation of the opioid pain treatment&#xD;
      is made during the oncological consultation which is the only possibility to recruit patients&#xD;
      for this pilot study. The way the clinic runs today, the nursing staff is timewise only&#xD;
      available for training patients with parenteral therapy. If the patients needed more time to&#xD;
      think about it, they would have to be trained separately at a later point in time, which&#xD;
      would only be established if the effectiveness of the patient training could be proven.&#xD;
      Because the patients are not exposed to any risk from the planned interventions, this&#xD;
      procedure is reasonable in our view.&#xD;
&#xD;
      In micro-training (study intervention), patients are taught structured knowledge based on the&#xD;
      content of a checklist. In addition to pain recording, patients are trained in the use of&#xD;
      basic and reserve pain medication and co-analgesics, the most common opioid side effects are&#xD;
      discussed and how to react to them. It is also checked that the necessary prescriptions or&#xD;
      medication have been given. Furthermore, after completing the BQII Barriers Questionnaire&#xD;
      (second part of the questionnaire), patient-related barriers, i.e. concerns or fears of the&#xD;
      patient with regard to pain therapy, become apparent. With a factual discussion and a&#xD;
      professional weighing of advantages and disadvantages, the nurse tries to break down these&#xD;
      barriers and thus promotes the patient's motivation for a well-adapted pain therapy. In the&#xD;
      case of sham intervention (control intervention), there is only a conversation between the&#xD;
      nurse and the patient. In this conversation the patient is picked up with his current&#xD;
      knowledge about his pain therapy and any questions are answered correctly. However, there is&#xD;
      no structured transfer of knowledge in the sense of patient training.&#xD;
&#xD;
      The data is recorded using a three-part questionnaire. The first part of the questionnaire&#xD;
      contains questions regarding pain-related restrictions in everyday activities (using the&#xD;
      Brief Pain Inventory as the standard for pain assessment of oncological patients as used by&#xD;
      the Swiss Cancer League). The second part of the questionnaire deals with patient-related&#xD;
      barriers using the BQII Barriers Questionnaire. The third part of the questionnaire consists&#xD;
      of global questions: confidence in dealing with pain medication, satisfaction with pain&#xD;
      therapy, restriction of the most important activities in everyday life and satisfaction with&#xD;
      quality of life.&#xD;
&#xD;
      4 weeks after the intervention, patients are asked to fill in the same three-part&#xD;
      questionnaire again. At that time, the questionnaire is sent to them by mail with a reply&#xD;
      envelope.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 31, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Data analysis with statistical process control:&#xD;
Data is collected in two time series. First, data of patients with sham intervention (control intervention) is collected, then data is collected from patients with a structured micro-training (study intervention).</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Patients do not know which training series they belong to.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain-related restriction of daily activities</measure>
    <time_frame>18 months</time_frame>
    <description>Questionnaire part 1: according to the Brief Pain Inventory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in patient-related barriers</measure>
    <time_frame>18 months</time_frame>
    <description>Questionnaire part 2: according to the BQII Barriers Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Confidence in handling pain medication, satisfaction with pain therapy and quality of life, restriction of the most important activities in everyday life</measure>
    <time_frame>18 months</time_frame>
    <description>Questionnaire part 3: recorded with global questions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Patient Empowerment</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 patients receive micro-training based on a checklist &amp; targeted discussion / dismantling of patient-related barriers based on the answers in the second part of the questionnaire (BQII Barriers Questionnaire)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>30 patients receive a sham intervention: an unstructured conversation is carried out. Patient questions are answered correctly, but there is no training, rather patient information.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Micro-training to promote self-management in pain therapy</intervention_name>
    <description>Micro-training according to the checklist &amp; targeted discussion / dismantling of patient-related barriers based on the answers in the second part of the questionnaire (BQII Barriers Questionnaire) In this discussion, the nurses give their opinion on any patient-related barriers that become apparent after completing the second part of the questionnaire. This is not done according to a fixed template, but with the specialist knowledge and everyday experience of the nurse.</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham intervention</intervention_name>
    <description>An unstructured conversation is carried out. Patient questions are answered correctly, but there is no training, rather patient information.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        â€¢ Oncology clinics outpatients with parenteral therapy with a new or escalated opioid pain&#xD;
        therapy without exclusion criteria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lack of consent&#xD;
&#xD;
          -  Insufficient knowledge of German&#xD;
&#xD;
          -  Cognitive deficits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabia Buettcher, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Luzerner Kantonsspital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabia Buettcher, MD</last_name>
    <phone>+41 41 205 1344</phone>
    <email>fabia.buettcher@luks.ch</email>
  </overall_contact>
  <reference>
    <citation>Raphaelis S, Frommlet F, Mayer H, Koller A. Implementation of a nurse-led self-management support intervention for patients with cancer-related pain: a cluster randomized phase-IV study with a stepped wedge design (EvANtiPain). BMC Cancer. 2020 Jun 16;20(1):559. doi: 10.1186/s12885-020-06729-0.</citation>
    <PMID>32546177</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>February 26, 2021</last_update_submitted>
  <last_update_submitted_qc>February 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

